BPC-157/TB-500 Wolverine Combo (10mg/10mg)
$110.00
Third Party Verified
Description
⚠️ LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION
This product is supplied exclusively for in vitro and laboratory research by qualified personnel. It is not approved by the FDA for any clinical, therapeutic, diagnostic, cosmetic, dietary, or veterinary application.
BPC-157 / TB-500 Combination (10 mg / 10 mg)
This research kit supplies two well-characterized synthetic peptides — BPC-157, a 15-residue sequence derived from a gastric juice protein, and TB-500, a synthetic fragment of thymosin β4 — co-packaged for laboratories studying angiogenesis, extracellular-matrix remodeling, actin dynamics, and cell-migration pathways in parallel. Each peptide is supplied as a lyophilized powder, 10 mg, for independent or combined experimental designs.
Product Specifications
| Product Name | BPC-157 / TB-500 Combination |
| Component 1 | BPC-157 — CAS 137525-51-0; C₆₂H₉₈N₁₆O₂₂; ≈1,419 g/mol; Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Component 2 | TB-500 — CAS 77591-33-4; C₂₁₂H₃₅₀N₅₆O₇₈S; ≈4,963 g/mol; 43-residue thymosin β4 fragment |
| Quantity | 10 mg + 10 mg (separate vials) |
| Form | Lyophilized powder |
| Purity | ≥98% (HPLC); see third-party COA |
| Classification | Synthetic peptides — research reagents |
Mechanistic Background
BPC-157 has been investigated for its influence on nitric-oxide signaling, growth-factor receptor expression, and endothelial pathways in laboratory models. TB-500 corresponds to the actin-binding region of thymosin β4 and is used to probe actin sequestration, cell motility, and extracellular-matrix organization. Co-packaging enables researchers to compare these mechanisms within a single experimental framework.
Research Applications
The two compounds are studied individually and in combination in cell-culture and preclinical model systems to examine:
- Angiogenesis signaling — VEGF, VEGFR2, and endothelial-cell migration assays
- Actin sequestration and cytoskeletal dynamics (TB-500 / thymosin β4 pathway)
- Fibroblast migration, proliferation, and collagen deposition in matrix models
- Nitric-oxide system and growth-factor receptor expression readouts
- Cytokine and inflammatory-mediator expression in cell-culture systems
- Comparative and synergy studies between the two peptides in shared pathway assays
Storage & Handling
Store lyophilized material at −20 °C, protected from light and moisture. Allow the vial to reach room temperature before opening. Following reconstitution in a suitable laboratory buffer, store at 2–8 °C and use within the timeframe established by your laboratory’s stability protocols. Avoid repeated freeze–thaw cycles. Handle in accordance with standard laboratory practice for peptide reagents.
Published Literature
- Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857–865.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37–51.
Research Use Only Statement
BPC-157 / TB-500 Combination (10 mg / 10 mg) is a chemical reagent supplied solely for laboratory research and analytical purposes. It is not a drug, dietary supplement, cosmetic, food additive, or medical device, and it has not been evaluated by the U.S. Food and Drug Administration. It is not intended to diagnose, treat, cure, or prevent any disease in humans or animals. Peptide Minds is a research chemical supplier and is not a pharmacy, compounding facility, or medical provider. The purchaser is responsible for ensuring the material is handled by trained personnel in accordance with all applicable laws, regulations, and institutional policies.
Additional information
| Quantity | 1 VIAL, 2 VIALS, 5 VIALS, 10 VIALS |
|---|---|
| Size | 10MG/10MG |













Reviews
There are no reviews yet.